Development and Characterization of a New Endoscopic Drug-Eluting Platform With Proven Efficacy in Acute and Chronic Experimental Colitis (vol 7, 415, 2020)


Por: Bon, I, Cano-Sarabia, M, de la Ossa, N, Bartoli, R and Lorenzo-Zuniga, V
Publicada: 26 oct 2021 Ahead of Print: 26 oct 2021
Resumen:
[This corrects the article DOI: 10.3389/fmed.2020.00415.].
Filiaciones:
:
 Hlth Res Inst Germans Trias & Pujol IGTP, Barcelona, Spain
Cano-Sarabia, M:
 CSIC, Catalan Inst Nanosci & Nanotechnol ICN2, Campus UAB, Bellaterra, Spain

 Barcelona Inst Sci & Technol, Campus UAB, Bellaterra, Spain
de la Ossa, N:
 Hosp Univ Gen Catalunya, Serv Anat Patol, Grp Quiron Salud, Barcelona, Spain
:
 Hlth Res Inst Germans Trias & Pujol IGTP, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
:
 Hlth Res Inst Germans Trias & Pujol IGTP, Barcelona, Spain

 Univ Hosp La Fe, Endoscopy Unit, Valencia, Spain
ISSN: 2296858X





FRONTIERS IN MEDICINE
Editorial
Frontiers Media S.A., AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND, Suiza
Tipo de documento: Correction
Volumen: 8 Número:
Páginas: 785148-785148
WOS Id: 000726464600001
ID de PubMed: 34765628
imagen Green Published, gold

MÉTRICAS